FDA advisers are currently undertaking a careful evaluation of Sarepta’s Duchenne gene therapy, a groundbreaking treatment that holds immense potential…
Ascendis’ Hormone Disorder Therapy Fails to Win Approval from US FDA
Ascendis Pharma has announced that its hormone disorder therapy has failed to win approval from the US Food and Drug…